MV BioTherapeutics SA

Swiss Biotech Association

Member

A Swiss microbiota biotherapeutics and mucosal vaccines company with two technology platforms: ApyraVax for the generation of innovative mucosal vaccines; ApyraMed with indication as enhancer in cancer immunotherapy and corrector of dysbiosis induced by antibiotic treatments and unhealthy diet.

https://www.mv-bio.com/
+41 58 666 72 25
fgrassi@mv-bio.com
Fabio Grassi

Location

Via Francesco Chiesa 5, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2018
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Alloy Therapeutics (Switzerland) AG

Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, peptides, cell therapy, and drug delivery.
Allschwil

Member

Pheida AG

Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water.
Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.
6039 Root

Member

plusbiome AG

plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.
4057 Basel

Member